Recently, the combination of CHOP-induced apoptosis and NLRP3 inflammasome-mediated pyroptosis has been demonstrated to be involved in the pathogenesis of experimental non-alcoholic steatohepatitis, which was successfully counteracted by treatment with TUDCA [14]. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatohepatitis.